No Data
No Data
Aldeyra Therapeutics' Resubmitted Marketing Application for Eye Disease Drug Accepted by FDA
AbbVie Gets European OK of Elahere in Platinum-Resistant Ovarian Cancer
Where Will AbbVie Be in 5 Years?
Wells Fargo Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $195
AbbVie Snaps Eight Straight Sessions of Losses
S&P Sees Some Signs of a US Credit Bubble as Spreads Tighten
No Data
No Data
102171590 : imagine it crashes to 53